NCT07136493 2026-03-05
Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer
City of Hope Medical Center
Phase NA Suspended
Clinical Trials
5 trialsNCT02993068 2026-02-19
Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)
M.D. Anderson Cancer Center
Phase NA Suspended
NCT05989828 2026-01-14
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
University of Southern California
Phase 1 Suspended
NCT04803084 2024-11-20
Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment
Vanderbilt-Ingram Cancer Center
Suspended
NCT04250818 2021-05-19
Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile
Texas Tech University Health Sciences Center, El Paso
Suspended